Literature DB >> 16796357

Heat and mass transfer scale-up issues during freeze-drying, III: control and characterization of dryer differences via operational qualification tests.

S Rambhatla1, S Tchessalov, Michael J Pikal.   

Abstract

The objective of this research was to estimate differences in heat and mass transfer between freeze dryers due to inherent design characteristics using data obtained from sublimation tests. This study also aimed to provide guidelines for convenient scale-up of the freeze-drying process. Data obtained from sublimation tests performed on laboratory-scale, pilot, and production freeze dryers were used to evaluate various heat and mass transfer parameters: nonuniformity in shelf surface temperatures, resistance of pipe, refrigeration system, and condenser. Emissivity measurements of relevant surfaces such as the chamber wall and the freeze dryer door were taken to evaluate the impact of atypical radiation heat transfer during scale-up. "Hot" and "cold" spots were identified on the shelf surface of different freeze dryers, and the impact of variation in shelf surface temperatures on the primary drying time and the product temperature during primary drying was studied. Calculations performed using emissivity measurements on different freeze dryers suggest that a front vial in the laboratory lyophilizer received 1.8 times more heat than a front vial in a manufacturing freeze dryer operating at a shelf temperature of -25 degrees C and a chamber pressure of 150 mTorr during primary drying. Therefore, front vials in the laboratory are much more atypical than front vials in manufacturing. Steady-state heat and mass transfer equations were used to study a combination of different scale-up issues pertinent during lyophilization cycles commonly used for the freeze-drying of pharmaceuticals.

Mesh:

Substances:

Year:  2006        PMID: 16796357      PMCID: PMC2750325          DOI: 10.1208/pt070239

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  19 in total

1.  NMR characterisation and transdermal drug delivery potential of microemulsion systems.

Authors:  M Kreilgaard; E J Pedersen; J W Jaroszewski
Journal:  J Control Release       Date:  2000-12-03       Impact factor: 9.776

Review 2.  Novel mechanisms and devices to enable successful transdermal drug delivery.

Authors:  B W Barry
Journal:  Eur J Pharm Sci       Date:  2001-09       Impact factor: 4.384

Review 3.  Passive skin penetration enhancement and its quantification in vitro.

Authors:  K Moser; K Kriwet; A Naik; Y N Kalia; R H Guy
Journal:  Eur J Pharm Biopharm       Date:  2001-09       Impact factor: 5.571

4.  Simulation of skin permeability in chitosan membranes.

Authors:  H Dureja; A K Tiwary; S Gupta
Journal:  Int J Pharm       Date:  2001-02-01       Impact factor: 5.875

Review 5.  Hydrogels: from controlled release to pH-responsive drug delivery.

Authors:  Piyush Gupta; Kavita Vermani; Sanjay Garg
Journal:  Drug Discov Today       Date:  2002-05-15       Impact factor: 7.851

Review 6.  Influence of microemulsions on cutaneous drug delivery.

Authors:  Mads Kreilgaard
Journal:  Adv Drug Deliv Rev       Date:  2002-11-01       Impact factor: 15.470

7.  The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins.

Authors:  Lalatendu Panigrahi; Snigdha Pattnaik; Saroj K Ghosal
Journal:  AAPS PharmSciTech       Date:  2005-09-30       Impact factor: 3.246

8.  The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole.

Authors:  H M El Laithy; K M F El-Shaboury
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

9.  Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula.

Authors:  Elvira Escribano; Ana Cristina Calpena; Josep Queralt; Rossend Obach; Jose Doménech
Journal:  Eur J Pharm Sci       Date:  2003-07       Impact factor: 4.384

10.  In-vitro release of diclofenac diethylammonium from lipid-based formulations.

Authors:  Siamak Parsaee; Mohammad N Sarbolouki; Mohamad Parnianpour
Journal:  Int J Pharm       Date:  2002-07-08       Impact factor: 5.875

View more
  7 in total

1.  Effects of vial packing density on drying rate during freeze-drying of carbohydrates or a model protein measured using a vial-weighing technique.

Authors:  Henning Gieseler; Geoffrey Lee
Journal:  Pharm Res       Date:  2007-11-13       Impact factor: 4.200

2.  Quality by design: scale-up of freeze-drying cycles in pharmaceutical industry.

Authors:  Roberto Pisano; Davide Fissore; Antonello A Barresi; Massimo Rastelli
Journal:  AAPS PharmSciTech       Date:  2013-07-25       Impact factor: 3.246

Review 3.  Emerging freeze-drying process development and scale-up issues.

Authors:  Sajal Manubhai Patel; Michael J Pikal
Journal:  AAPS PharmSciTech       Date:  2011-02-23       Impact factor: 3.246

4.  Finite Element Method (FEM) Modeling of Freeze-drying: Monitoring Pharmaceutical Product Robustness During Lyophilization.

Authors:  Xiaodong Chen; Vikram Sadineni; Mita Maity; Yong Quan; Matthew Enterline; Rao V Mantri
Journal:  AAPS PharmSciTech       Date:  2015-03-20       Impact factor: 3.246

5.  Process and Formulation Effects on Protein Structure in Lyophilized Solids Using Mass Spectrometric Methods.

Authors:  Lavanya K Iyer; Gregory A Sacha; Balakrishnan S Moorthy; Steven L Nail; Elizabeth M Topp
Journal:  J Pharm Sci       Date:  2016-04-01       Impact factor: 3.534

6.  Investigation of Formulation and Process of Lyophilised Orally Disintegrating Tablet (ODT) Using Novel Amino Acid Combination.

Authors:  Farhan AlHusban; Amr M ElShaer; Jiteen H Kansara; Alan M Smith; Liam M Grover; Yvonne Perrie; Afzal R Mohammed
Journal:  Pharmaceutics       Date:  2010-01-04       Impact factor: 6.321

7.  LyoPRONTO: an Open-Source Lyophilization Process Optimization Tool.

Authors:  Gayathri Shivkumar; Petr S Kazarin; Andrew D Strongrich; Alina A Alexeenko
Journal:  AAPS PharmSciTech       Date:  2019-10-31       Impact factor: 3.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.